Development of 2-Pyrrolidinyl-N-methyl Pyrimidones as Potent and Orally Bioavailable HIV Integrase Inhibitors.

Among a series of title compounds, the derivative (I) is shown to represent a promising agent against HIV-1 and is the subject of further studies.